We are delighted to feature a blog post by Kate Gajewska, a diabetes educator and doctoral candidate in Royal College of Surgeons in Ireland, who spoke about the history of diabetes and her personal experience with type 1 diabetes at a recent DCRC event. Kate's blog article includes the history of diabetes and the importance of the patient voice highlighting the UCD DCRC Patient Voice in Diabetes Research event.
On June 25–26, 2018, the New York Academy of Sciences hosted Resolution of Inflammation, Infection and Tissue Regeneration, a symposium featuring many of the top researchers in the rapidly developing field of resolution pharmacology including Professor Catherine Godson, UCD Professor of Molecular Medicine and Director, UCD Diabetes Complications Research Centre among the keynote speakers. In two days of oral presentations, a poster session, and an extensive panel discussion, speakers and attendees reviewed the biggest advances and challenges in resolution biology. The meeting covered the basic biology of inflammation and its resolution, studies on animal models of chronic and acute diseases, and clinical trials of promising new inflammation-resolving drugs.
The UCD Diabetes Complications Research Centre are delighted to welcome students from Tallaght Community School to a Summer School from Monday 20th - Thursday 23rd August 2018, at the UCD Conway Institute. We hope that the event will give our guests an insight into scientific research and might inspire career choices.
This video by The Economist examines the impact of bariatric surgery as a potential therapy for the remission of Type 2 Diabetes.
The inaugural Patient Voice in Diabetes Research event takes place on Wednesday 13th June 2018 from 5:30-9pm in the UCD Charles Institute. This event is free but registration is required.
The 4th World Congress on Interventional Therapies for Type 2 Diabetes takes place from 8th - 10th April 2019 at the Hilton Midtown, New York City. Further details from www.wcitd.com.
Prof Carel Le Roux describes in layperson's terms a summary of a clinical trial comparing semaglutide with dulaglutide when administered with metformin in the treatment of people with Type 2 diabetes.
Keystone Symposia on Molecular and Cellular Biology present 'The Resolution of Inflammation in Health and Disease' conference from 24th to 28th March 2018 at the Royal Dublin Society, Dublin. The scientiifc organising committee includes Prof Catherine Godson, UCD Professor of Molecular Medicine.